News

Strong Study News

31 March 2014

The “STRONG” Consortium has been established to study Neovascular Glaucoma secondary to ischemic Central Retinal Vein Occlusion (i-CRVO), a rare eye disease. Aganirsen antisense oligonucleotide topical eye emulsion will be used for “STRONG Study”, the…

Read more